Market Overview:
The global clostridium diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of clostridium-related diseases, rising demand for accurate and rapid diagnosis, and technological advancements in clostridium diagnostics. Clostridium difficile is the most commonly diagnosed type of clostridium and accounts for majority of cases. Clostridium perfringens is the second most common type of clostrdiuum and causes food poisoning, gangrene, and other serious infections. Clstidrium botulinum is a rare but deadly form of bacteria that can cause botulism, a paralytic illness. Clstidrium tetani causes tetanus, an infection that leads to muscle spasms and convulsions.
Product Definition:
Clostridium diagnostics is the process of identifying and diagnosing infections caused by Clostridium bacteria. This type of diagnostic testing is important because it can help healthcare providers determine the best course of treatment for patients who have been infected with these bacteria.
Clostridium Difficile:
Clostridium difficile is an infectious microorganism, which causes severe diarrhea in the patient. It affects the intestinal tract of human beings causing abdominal pain and diarrhea. The major symptoms associated with this disease are loose stools, fever & stomach cramps and nausea.
Clostridium Perfringens:
Clostridium perfringens is an infectious bacteria that causes food poisoning. It can be found in the soil, water, and animals. The bacteria enter the human body through contaminated food or water and multiply in the intestinal tract causing serious damage to vital organs such as kidneys, liver and heart.
Application Insights:
The others segment held the largest share of more than 60.0% in 2017. The growth can be attributed to an increase in number of diagnostic laboratories and clinics that perform clostridium testing without prior approval from the government authorities or institutional review boards. These are usually referred to as direct-to-consumer (DTC) tests, which offer easy access to consumers with no medical expertise involved in decision making process regarding diagnosis and treatment options for clostridium infection.
Hospitals accounted for a significant share in the global market owing to rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases along with increasing number of surgeries across regions worldwide.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, increasing prevalence of chronic diseases, and rising awareness about early diagnosis are some factors responsible for North America’s dominance. Moreover, the availability of a wide range of products with improved diagnostic techniques is anticipated to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to improving healthcare infrastructure and growing demand for Clostridium diagnostics in emerging countries such as China and India due to rising incidence rates of infectious diseases such as botulism, tetanus & diphtheria along with C difficile infections in hospitals & clinics. In addition, favorable government initiatives promoting early diagnosis coupled with increasing R&D activities by private companies will also propel regional growth over the next eight years.
Growth Factors:
- Increasing incidence of Clostridium-associated diseases: The global incidence of Clostridium-associated diseases is increasing due to the changing lifestyle and food habits. This is expected to drive the demand for Clostridium diagnostics products and services in the coming years.
- Growing awareness about clostridial infections: There is a growing awareness among people about clostridial infections and their symptoms, which is likely to boost the demand for Clostridium diagnostics products in the near future.
- Technological advancements inClostridium diagnostics: The technological advancements inClostridium diagnostics are helping laboratories to detect these infections at an early stage, which is driving the growth of this market worldwide.
- Rising number of outbreaks associated withclustered cases: There has been a rise in number of outbreaks associated with clustered cases, which has led healthcare professionals to adoptClosrtiduum diagnostics for better patient management and control measures.. This trend is expected to continue during the forecast period, thereby propellingthe growth of this market globally . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Clostridium Diagnostics Market Research Report
By Type
Clostridium Difficile, Clostridium Perfringens, Clostridium Botulinum, Clostridium Tetani, Clostridium Sordellii
By Application
Hospitals, Independent Laboratories, Clinics, Others
By Companies
Abbott, Beckman Coulter, Olympus, Siemens Healthineers, F. Hoffmann-La Roche, BD, bioMerieux, Chrono-log, Corgenix, Diazyme Laboratories, FUJIREBIO DIAGNOSTICS, Hologic, QIAGEN, Sysmex, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Clostridium Diagnostics Market Report Segments:
The global Clostridium Diagnostics market is segmented on the basis of:
Types
Clostridium Difficile, Clostridium Perfringens, Clostridium Botulinum, Clostridium Tetani, Clostridium Sordellii
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Independent Laboratories, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Beckman Coulter
- Olympus
- Siemens Healthineers
- F. Hoffmann-La Roche
- BD
- bioMerieux
- Chrono-log
- Corgenix
- Diazyme Laboratories
- FUJIREBIO DIAGNOSTICS
- Hologic
- QIAGEN
- Sysmex
- Thermo Fisher Scientific
Highlights of The Clostridium Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Clostridium Difficile
- Clostridium Perfringens
- Clostridium Botulinum
- Clostridium Tetani
- Clostridium Sordellii
- By Application:
- Hospitals
- Independent Laboratories
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clostridium Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clostridium Diagnostics is a laboratory company that provides diagnostic testing and services for Clostridium difficile infections.
Some of the key players operating in the clostridium diagnostics market are Abbott, Beckman Coulter, Olympus, Siemens Healthineers, F. Hoffmann-La Roche, BD, bioMerieux, Chrono-log, Corgenix, Diazyme Laboratories, FUJIREBIO DIAGNOSTICS, Hologic, QIAGEN, Sysmex, Thermo Fisher Scientific.
The clostridium diagnostics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clostridium Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clostridium Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clostridium Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clostridium Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clostridium Diagnostics Market Size & Forecast, 2020-2028
4.5.1 Clostridium Diagnostics Market Size and Y-o-Y Growth
4.5.2 Clostridium Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Clostridium Difficile
5.2.2 Clostridium Perfringens
5.2.3 Clostridium Botulinum
5.2.4 Clostridium Tetani
5.2.5 Clostridium Sordellii
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Independent Laboratories
6.2.3 Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clostridium Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clostridium Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Clostridium Difficile
9.6.2 Clostridium Perfringens
9.6.3 Clostridium Botulinum
9.6.4 Clostridium Tetani
9.6.5 Clostridium Sordellii
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Independent Laboratories
9.10.3 Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Clostridium Difficile
10.6.2 Clostridium Perfringens
10.6.3 Clostridium Botulinum
10.6.4 Clostridium Tetani
10.6.5 Clostridium Sordellii
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Independent Laboratories
10.10.3 Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Clostridium Difficile
11.6.2 Clostridium Perfringens
11.6.3 Clostridium Botulinum
11.6.4 Clostridium Tetani
11.6.5 Clostridium Sordellii
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Independent Laboratories
11.10.3 Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Clostridium Difficile
12.6.2 Clostridium Perfringens
12.6.3 Clostridium Botulinum
12.6.4 Clostridium Tetani
12.6.5 Clostridium Sordellii
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Independent Laboratories
12.10.3 Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Clostridium Difficile
13.6.2 Clostridium Perfringens
13.6.3 Clostridium Botulinum
13.6.4 Clostridium Tetani
13.6.5 Clostridium Sordellii
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Independent Laboratories
13.10.3 Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clostridium Diagnostics Market: Competitive Dashboard
14.2 Global Clostridium Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Beckman Coulter
14.3.3 Olympus
14.3.4 Siemens Healthineers
14.3.5 F. Hoffmann-La Roche
14.3.6 BD
14.3.7 bioMerieux
14.3.8 Chrono-log
14.3.9 Corgenix
14.3.10 Diazyme Laboratories
14.3.11 FUJIREBIO DIAGNOSTICS
14.3.12 Hologic
14.3.13 QIAGEN
14.3.14 Sysmex
14.3.15 Thermo Fisher Scientific
